| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/02/2009 | CN101518566A Non-oral preparation of guava leaf total flavonoid aglycone, preparation method and application thereof |
| 09/02/2009 | CN101518563A Non-oral preparation of pachyrhizua angulatus total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518562A Non-oral preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518561A Oral medicinal preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518557A Preparation method of apium graveolen capsules |
| 09/02/2009 | CN101518555A Evening primrose oil dropping pill used for preventing and treating arteriosclerosis and preparation method thereof |
| 09/02/2009 | CN101518554A Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518540A Medical composition |
| 09/02/2009 | CN101518536A Ease blood pressure reducing capsule |
| 09/02/2009 | CN101518524A Methods of inhibiting vascular permeability and apoptosis |
| 09/02/2009 | CN101518515A Cytidine disodium triphosphate freeze-dried powder-injection for injection |
| 09/02/2009 | CN101518513A Cinepazide maleate lipid microspheres preparation and preparation method thereof |
| 09/02/2009 | CN101518510A Method for preparing tanshinone micelle |
| 09/02/2009 | CN101518509A Oral drug combination containing salvianolic acid A |
| 09/02/2009 | CN100535013C Selective targeting of tumor vasculature using antibody molecules |
| 09/02/2009 | CN100534997C C-aryl glucoside SGLT2 inhibitors and method |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534968C Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal |
| 09/02/2009 | CN100534427C Ginkgo leaf extract and its preparation |
| 09/01/2009 | US7582797 4,4'-dithiobis-(3,3'-amino-6,6'-phenyl-1,1'-hexanesulfonic) acid; hypotensive agents for cardiovascular disorders, arterial hypertension, cardiac insufficiency and renal failure, myocardial infarction diabetic proteinuria |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582730 an iron-regulated protein found in Neisseria gonorrhoeae or Neisseria meningitidis outer membranes; immunizing a host against gonococcal and meningococcal diseases, such as gonorrhea, meningitis |
| 09/01/2009 | US7582675 Flavonoid compound and process for producing the same |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
| 09/01/2009 | US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders |
| 09/01/2009 | US7582619 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/01/2009 | CA2403977C .gamma.-tocotrienol-containing diuretics |
| 09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/01/2009 | CA2274469C Serum-derived factor inducing cell differentiation and medical uses thereof |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009105722A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105717A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105712A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | WO2009105675A1 Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
| 08/27/2009 | WO2009105624A2 Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity |
| 08/27/2009 | WO2009105265A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 08/27/2009 | WO2009105231A1 Compositions and methods for treating vascular disorders |
| 08/27/2009 | WO2009105023A1 Pharmaceutical formulation comprising oxabispidines / 236 |
| 08/27/2009 | WO2009104983A1 Method to increase sexual potency with the aid of "sex spectacles" |
| 08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | WO2009104248A1 Adrenomedullin production enhancer |
| 08/27/2009 | WO2009103710A1 Substituted 4-hydroxy-n- (4-hydroxyphenyl) indoles as estrogenic agents |
| 08/27/2009 | WO2009103440A1 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 08/27/2009 | WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
| 08/27/2009 | WO2009103123A1 Dendrimeric enzyme inhibitors |
| 08/27/2009 | WO2009075835A8 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 08/27/2009 | WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof |
| 08/27/2009 | WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent |
| 08/27/2009 | WO2009033667A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2008116145A3 Soluble epoxide hydrolase inhibitors |
| 08/27/2009 | WO2007079003A3 Amide inhibitors of leukotriene a4 hydrolase |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215895 Therapeutic and carrier molecules |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215843 Tetrazole Derivatives and Their Use for the Treatment of Cardiovascular Diseases |
| 08/27/2009 | US20090215836 Roflumilast for the Treatment of Pulmonary Hypertension |
| 08/27/2009 | US20090215809 crystalline calcium (3S)-{[(1R)-isobutanoyloxyethoxy]carbonylaminomethyl}-5-methyl-hexanoate hydrate; sustained release oral dosage formualtion with opioid agonist, selective serotonin re-uptake inhibitor and noradrenaline re-uptake inhibitor; an inflammatory disease, neuropathic pain, anxiety, psychosis |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215782 Use of PDE-5 Inhibitors for Endothelial Repair of Tissues Impaired by Trauma or Disease |
| 08/27/2009 | US20090215763 Substituted benzoxazinones |
| 08/27/2009 | US20090215756 Formulations containing losartan and/or its salts |
| 08/27/2009 | US20090215755 Use of a pyrazole derivative for preparing medicinal products that are useful in the prevention and treatment of dyslipidaemias and of diseases related to dyslipidaemias and/or to obesity |
| 08/27/2009 | US20090215748 FXR agonists for treating vitamin D associated diseases |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215716 Nitroguanosine-3' 5'-cyclic monophosphate compound and protein kinase g activating agent |
| 08/27/2009 | US20090215697 Composition for the treatment of atherosclerosis |
| 08/27/2009 | US20090215688 GLP-I Agonist And Cardiovascular Complications |
| 08/27/2009 | US20090215675 Means for the inhibition of anti-beta1-adrenergic receptor antibodies |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090214675 4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 08/27/2009 | US20090214654 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 08/27/2009 | US20090214643 Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
| 08/27/2009 | US20090214624 Topical nitric oxide donor devices and methods for their therapeutic use |
| 08/27/2009 | US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214481 Treatment of ischemia using stem cells |
| 08/27/2009 | CA2716332A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2716330A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2715962A1 Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
| 08/27/2009 | CA2715872A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | CA2715771A1 Adrenomedullin production enhancer |
| 08/27/2009 | CA2714700A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | CA2714654A1 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |